Sarcoidosis
2007

Understanding Sarcoidosis: A Comprehensive Review

publication Evidence: moderate

Author Information

Author(s): Nunes Hilario, Bouvry Diane, Soler Paul, Valeyre Dominique

Primary Institution: Service de Pneumologie, Hôpital Avicenne, Assistance Publique Hôpitaux de Paris et Faculté de Médecine, Université Paris-Nord

Hypothesis

Various unidentified antigens, either infectious or environmental, could trigger an exaggerated immune reaction in genetically susceptible hosts.

Conclusion

Sarcoidosis is a complex disease with variable manifestations and outcomes, often requiring careful management and treatment.

Supporting Evidence

  • Sarcoidosis affects primarily young and middle-aged adults.
  • The disease can resolve spontaneously in many cases within 12 to 36 months.
  • Systemic corticosteroids are the mainstay of treatment for sarcoidosis.
  • Mortality from sarcoidosis is estimated to be between 0.5% and 5%.
  • Incidence rates vary significantly based on demographic factors such as race and gender.

Takeaway

Sarcoidosis is a disease where your body's immune system creates lumps in different organs, and it can affect anyone, but it often gets better on its own.

Methodology

The review summarizes existing literature on sarcoidosis, including its epidemiology, clinical presentation, diagnosis, and treatment options.

Limitations

The review may not cover all recent studies or emerging treatments due to the vast and evolving nature of sarcoidosis research.

Participant Demographics

Primarily young and middle-aged adults, with variations in incidence based on race and gender.

Digital Object Identifier (DOI)

10.1186/1750-1172-2-46

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication